Viewing Study NCT02641002

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-03-03 @ 3:03 PM
Study NCT ID: NCT02641002
Status: TERMINATED
Last Update Posted: 2018-10-18
First Post: 2015-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myeloid, Acute View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CC-90002 View
None Monoclonal View
None Antibody View
None CD47 View
None Hematologic Cancers View
None Acute Myeloid Leukemia View
None AML View
None Myelodysplastic syndrome View
None MDS View
None Blood disorder View